Jumalon, Jesee C.
HRN: 28-01-02 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/06/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/06/2025
11/06/2025
IV
750mg
Q8
Amoebiasis
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes